Search Results

GSK744 (S/GSK1265744) 10mM (in 1mL DMSO)  | 99.65%

APEXBIO TECHNOLOGY LLC

HIV integrase inhibitor, oral active and long-acting Proteases|HIV Integrase

More Information Supplier Page

×

GSK744 (S/GSK1265744)

GSK744 (S/GSK1265744) 5mg  | 99.65%

APEXBIO TECHNOLOGY LLC

HIV integrase inhibitor, oral active and long-acting Proteases|HIV Integrase

More Information Supplier Page

×

GSK744 (S/GSK1265744)

GSK744 (S/GSK1265744) 10mg  | 99.65%

APEXBIO TECHNOLOGY LLC

HIV integrase inhibitor, oral active and long-acting Proteases|HIV Integrase

More Information Supplier Page

×

GSK744 (S/GSK1265744)

Purvalanol B 5mg  | 95.78%

APEXBIO TECHNOLOGY LLC

CDK1/CDK2/CDK4 inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

Purvalanol B

Purvalanol B 10mM (in 1mL DMSO)  | 95.78%

APEXBIO TECHNOLOGY LLC

CDK1/CDK2/CDK4 inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

Purvalanol B

BI6727 (Volasertib) 100mg  | 99.78%

APEXBIO TECHNOLOGY LLC

Plk inhibitor,highly potent Cell Cycle/Checkpoint|PLK

More Information Supplier Page

×

BI6727 (Volasertib)

BI6727 (Volasertib) 50mg  | 99.78%

APEXBIO TECHNOLOGY LLC

Plk inhibitor,highly potent Cell Cycle/Checkpoint|PLK

More Information Supplier Page

×

BI6727 (Volasertib)

BI6727 (Volasertib) 10mg  | 99.78%

APEXBIO TECHNOLOGY LLC

Plk inhibitor,highly potent Cell Cycle/Checkpoint|PLK

More Information Supplier Page

×

BI6727 (Volasertib)

TAE226 (NVP-TAE226) 5mg  | 99.11%

APEXBIO TECHNOLOGY LLC

FAK inhibitor,potent and ATP-competitive Tyrosine Kinase|FAK

More Information Supplier Page

×

TAE226 (NVP-TAE226)

TAE226 (NVP-TAE226) 10mg  | 99.11%

APEXBIO TECHNOLOGY LLC

FAK inhibitor,potent and ATP-competitive Tyrosine Kinase|FAK

More Information Supplier Page

×

TAE226 (NVP-TAE226)